John Overdeck’s Varian Medical Systems, Inc. VAR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-122,192
Closed -$21.4M 4396
2020
Q4
$21.4M Buy
122,192
+117,424
+2,463% +$20.4M 0.06% 340
2020
Q3
$820K Buy
+4,768
New +$750K ﹤0.01% 1897
2019
Q4
Sell
-63,839
Closed -$8.14M 4117
2019
Q3
$7.6M Buy
63,839
+50,681
+385% +$6.03M 0.03% 669
2019
Q2
$1.79M Sell
13,158
-105,167
-89% -$14.1M 0.01% 1515
2019
Q1
$16.8M Sell
118,325
-129,231
-52% -$17M 0.05% 455
2018
Q4
$28.1M Buy
247,556
+41,534
+20% +$4.75M 0.11% 246
2018
Q3
$23.1M Buy
206,022
+159,622
+344% +$18.1M 0.06% 385
2018
Q2
$5.28M Buy
+46,400
New +$5.55M 0.02% 987
2015
Q4
Sell
-244,733
Closed -$15.8M 3097
2015
Q3
$15.8M Buy
244,733
+44,138
+22% +$3.22M 0.08% 273
2015
Q2
$14.8M Buy
+200,595
New +$15.7M 0.07% 334
2014
Q3
Sell
-6,044
Closed -$441K 2166
2014
Q2
$441K Buy
+6,044
New +$434K ﹤0.01% 1670
2013
Q4
Sell
-162,104
Closed -$10.6M 2455
2013
Q3
$10.6M Buy
+162,104
New +$10.3M 0.07% 344

Other funds holding VAR

John Overdeck's VAR Position: Q1 2021 in Review

John Overdeck sold out of Varian Medical Systems, Inc. (VAR) in Q1 2021, closing a stake of 122,192 shares — an estimated $21.4M sold.

John Overdeck first reported a position in VAR in Q3 2013 and held it in 12 quarters. The position peaked at $28.1M in Q4 2018. 600 funds tracked by Wall St. Rank hold VAR as of Q1 2021.

  • John Overdeck reported no remaining Varian Medical Systems, Inc. position as of Q1 2021 after selling out during the quarter.
  • John Overdeck sold 122,192 Varian Medical Systems, Inc. shares in Q1 2021, an estimated $21.4M.
  • John Overdeck first reported a position in Varian Medical Systems, Inc. in Q3 2013 and held it in 12 quarters.
  • John Overdeck's Varian Medical Systems, Inc. position peaked at $28.1M in Q4 2018.
  • 600 funds tracked by Wall St. Rank held Varian Medical Systems, Inc. as of Q1 2021.

Based on Two Sigma Investments's 13F filing for Q1 2021, filed 17 May 2021.